Single‐Microglia Transcriptomic Transition Network‐based Prediction and Real‐world Patient Data Validation Identifies Ketorolac as a Repurposable Drug for Alzheimer’s Disease

Documenti analoghi

• Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
  di: Jielin Xu, et al.
  Pubblicazione: (2024)
• Propensity score models are better when post-calibrated
  di: Gutman, Rom, et al.
  Pubblicazione: (2022)
• Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
  di: Reina Tonegawa‐Kuji, et al.
  Pubblicazione: (2025)
• Traumatic Brain Injury‐associated gene network‐based prediction and population‐based validation identifies doxycycline as a repurposable medicine for Alzheimer’s Disease
  di: Marina Bykova, et al.
  Pubblicazione: (2025)
• Cross‐species protein interactome network‐based analysis of GWAS and human brain quantitative trait loci (x‐QTL) data identifies risk genes and drug targets for Alzheimer’s disease
  di: Jielin Xu, et al.
  Pubblicazione: (2024)